Patent details

EP2473170 Title: USE OF AEROSOLIZED LEVOFLOXACIN FOR TREATING CYSTIC FIBROSIS

Basic Information

Publication number:
EP2473170
PCT Application Number:
US2010047903
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP108145954
PCT Publication Number:
WO2011029059
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF AEROSOLIZED LEVOFLOXACIN FOR TREATING CYSTIC FIBROSIS
French Title of Invention:
UTILISATION DE LÉVOFLOXACINE EN AÉROSOL POUR TRAITER LA FIBROSE KYSTIQUE
German Title of Invention:
VERWENDUNG VON AEROSOLISIERTEM LEVOFLOXAZIN ZUR BEHANDLUNG VON ZYSTISCHER FIBROSE
SPC Number:

Dates

Filing date:
03/09/2010
Grant date:
19/06/2019
EP Publication Date:
11/07/2012
PCT Publication Date:
10/03/2011
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
19/06/2019
EP B1 Publication Date:
19/06/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
03/09/2030
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
15/01/2024
 
 

Name:
HORIZON THERAPEUTICS U.S. HOLDING LLC
Address:
1 Horizon Way, 60015, Deerfield, Illinois , United States (US)

History of Owners

From:
12/06/2019
To:
15/01/2024

Name:
Horizon Orphan LLC
Address:
150 South Saunders Road, Lake Forest, IL 60045, United States (US)

Agent

Name:
VALIPAT
From:
17/07/2019
Address:
Avenue Louise 54, 1050, Bruxelles, Belgium (BE)
To:

Inventor

1

Name:
LOUTIT, Jefferey, S.
Address:
United States (US)

2

Name:
LOMOVSKAYA, Olga
Address:
United States (US)

3

Name:
DUDLEY, Michael, N.
Address:
United States (US)

4

Name:
MORGAN, Elizabeth, E.
Address:
United States (US)

5

Name:
GRIFFITH, David, C.
Address:
United States (US)

Priority

1

Priority Number:
240092 P
Priority Date:
04/09/2009
Priority Country:
United States (US)

2

Priority Number:
249231 P
Priority Date:
06/10/2009
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/12; A61K 31/5383; A61K 33/06; A61P 11/00;

Publication

Bulletin

Bulletin Heading:
CO
Bulletin edition number:
2024/03
Publication date:
05/02/2024
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

1

Issue number:
201925
Publication date:
19/06/2019
Description:
Grant (B1)

2

Issue number:
201928
Publication date:
10/07/2019
Description:
Application number/publication number of the divisional application (Art. 76) changed

Deed

Power of attorney

Change Kind/ Decision Type:
Assignment
Deed Number:
RC20190000273A
Date Registered:
17/07/2019
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
VALIPAT
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Removed Pledgee

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Change of ownership
Deed Number:
RC20240000010A
Date Registered:
15/01/2024
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
MARKS & CLERK LLP
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
HORIZON THERAPEUTICS U.S. HOLDING LLC
Address:
1 Horizon Way, 60015, Deerfield, Illinois , United States (US)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
30/09/2026
Annual Fee Number:
17
Annual Fee Amount:
246 Euro
Expected Payer:
Last Annual Fee Payment Date:
20/08/2025
Last Annual Fee Paid Number:
16
Last Annual Fee Paid Amount:
230 Euro
Payer:
ANAQUA SERVICES (ANC. SGA2)
Filing date Document type Number of pages
18/07/2019 Outgoing Correspondence 1
15/01/2024 Request For Change 6
16/01/2024 Outgoing Correspondence 1
17/07/2019 Request For Change 2
13/03/2026 Request For Change 5
16/03/2026 Outgoing Correspondence 46